BioCentury
ARTICLE | Company News

Pharming other news

July 26, 2010 7:00 AM UTC

Pharming completed its partial spinout of DNage B.V. to DNage former shareholders, who received 49% of DNage and 5 million Pharming shares, worth €950,000 ($1.2 million) at Pharming's close price of ...